THERAPEUTIC TARGETING OF CENTROSOME ABNORMALITIES IN NF2-MUTANT TUMORS

$819,240FY2016Department of DefenseDOD

The General Hospital Corporation

Investigators

THERAPEUTIC TARGETING OF CENTROSOME ABNORMALITIES IN NF2-MUTANT TUMORS · GrantIndex